Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial

Autor: Ebata, Satoshi, Yoshizaki, Ayumi *, Oba, Koji, Kashiwabara, Kosuke, Ueda, Keiko, Uemura, Yukari, Watadani, Takeyuki, Fukasawa, Takemichi, Miura, Shunsuke, Yoshizaki-Ogawa, Asako, Okiyama, Naoko, Kodera, Masanari, Hasegawa, Minoru, Sato, Shinichi
Zdroj: In The Lancet Rheumatology August 2022 4(8):e546-e555
Databáze: ScienceDirect